Cargando…
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection
Low-dose human interleukin-2 (hIL-2) treatment is used clinically to treat autoimmune disorders due to the cytokine’s preferential expansion of immunosuppressive regulatory T cells (Tregs). However, off-target immune cell activation and short serum half-life limit the clinical potential of IL-2 trea...
Autores principales: | VanDyke, Derek, Iglesias, Marcos, Tomala, Jakub, Young, Arabella, Smith, Jennifer, Perry, Joseph A., Gebara, Edward, Cross, Amy R., Cheung, Laurene S., Dykema, Arbor G., Orcutt-Jahns, Brian T., Henclová, Tereza, Golias, Jaroslav, Balolong, Jared, Tomasovic, Luke M., Funda, David, Meyer, Aaron S., Pardoll, Drew M., Hester, Joanna, Issa, Fadi, Hunter, Christopher A., Anderson, Mark S., Bluestone, Jeffrey A., Raimondi, Giorgio, Spangler, Jamie B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631798/ https://www.ncbi.nlm.nih.gov/pubmed/36261022 http://dx.doi.org/10.1016/j.celrep.2022.111478 |
Ejemplares similares
-
De la línea al diseño : comunicación, diseño, grafismo
por: VanDyke, Scott, 1954- -
SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection
por: Dykema, Arbor G., et al.
Publicado: (2022) -
Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity
por: Leonard, Elissa K., et al.
Publicado: (2023) -
Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis
por: Rhodes, Kelly R., et al.
Publicado: (2023) -
Recent advances in our understanding of the allograft response
por: Hennessy, Conor, et al.
Publicado: (2021)